8 mars 2023
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2023.19.817.460
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/36883706
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_448D7597ED713
info:eu-repo/semantics/embargoedAccess , Restricted: cannot be viewed until 2024-09-08 , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
L. Dällenbach et al., « Prise en charge coordonnée de l’hypertension artérielle entre le praticien et les spécialistes - Place de la dénervation rénale dans l’HTA résistante [Coordinated management of arterial hypertension] », Serveur académique Lausannois, ID : 10.53738/REVMED.2023.19.817.460
Despite major therapeutic progress and the numerous poly-pill combinations available on the market today, the control of arterial hypertension remains widely insufficient. A multidisciplinary management putting together internal medicine, nephrology and cardiology specialist offers the best chances for patients to achieve their blood pressure goals, especially when suffering from resistant hypertension despite adequate prescription of the reference tri therapy: ACEI/ARA2 combined with a thiazide-like diuretic and calcium channel blocker. Recent studies and randomized trials from the last five years shed a new light on the value of renal denervation and its efficacy on lowering blood pressure. This will probably lead to the integration of this technique in the next guidelines and improve its adoption over the next years.